NCT02365597 2026-01-30
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
Janssen Research & Development, LLC
Phase 2 Active not recruiting
Clinical Trials
5 trialsNCT04557449 2025-10-01
CDK4i
Pfizer
Phase 2 Active not recruiting
NCT06111872 2025-03-25
Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.
National University of Malaysia
Phase 2 Completed
NCT03084536 2024-12-24
PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery
Washington University School of Medicine
Phase 2 Completed
NCT01687751 2015-05-25
Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients
Fraser Health
Phase 2 Withdrawn